右美托咪定停药后反跳性高血压的发生率

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Pub Date : 2019-10-01 DOI:10.1002/phar.2323

Lauren A Flieller, C. Alaniz, Melissa R. Pleva, James T. Miller

{"title":"右美托咪定停药后反跳性高血压的发生率","authors":"Lauren A Flieller, C. Alaniz, Melissa R. Pleva, James T. Miller","doi":"10.1002/phar.2323","DOIUrl":null,"url":null,"abstract":"To date, no studies have evaluated the incidence of rebound hypertension occurring with the discontinuation of long‐term (> 72 hrs) dexmedetomidine infusions. Rebound hypertension has been documented in the literature with clonidine, a structurally and pharmacologically similar medication.","PeriodicalId":19812,"journal":{"name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Incidence of Rebound Hypertension after Discontinuation of Dexmedetomidine\",\"authors\":\"Lauren A Flieller, C. Alaniz, Melissa R. Pleva, James T. Miller\",\"doi\":\"10.1002/phar.2323\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To date, no studies have evaluated the incidence of rebound hypertension occurring with the discontinuation of long‐term (> 72 hrs) dexmedetomidine infusions. Rebound hypertension has been documented in the literature with clonidine, a structurally and pharmacologically similar medication.\",\"PeriodicalId\":19812,\"journal\":{\"name\":\"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/phar.2323\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/phar.2323","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 5

摘要

到目前为止，还没有研究评估停止长期(> 72小时)右美托咪定输注后发生的反跳性高血压的发生率。反跳性高血压在文献中已被证实与可乐定，一种结构和药理学上相似的药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Incidence of Rebound Hypertension after Discontinuation of Dexmedetomidine

To date, no studies have evaluated the incidence of rebound hypertension occurring with the discontinuation of long‐term (> 72 hrs) dexmedetomidine infusions. Rebound hypertension has been documented in the literature with clonidine, a structurally and pharmacologically similar medication.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

自引率

0.00%

发文量